This study was designed to identify factors that significantly alter the magnitude and duration of suxamethonium-induced neuromuscu/ar block in patients with an apparently normal genotype for pseudocholinesterase. One hundred and fifty-six adults (ages 18-65 yr) were allocated to 13 subgroups. Patients in each subgroup received suxamethonium 50-2000 ug kg-'. The mechano-graphic response of the adductor pollicis brevis muscle to ulnar nerve stimulation was recorded. The ED so was found to be 167 fig kg'1, EDX was 316 ng kg-1 and EDgs was 392 fig kg-'. The dur-ation of action (AX) was in agreement with earlier published results. The magnitude of block was dose-related and decreased with increasing onset time (ton) and pseudocho...
Mivacurium chloride is a new non-depolarizing neuromuscular blocking drug, structurally related to a...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
Vecuronium has a shorter duration of action than pancuronium and recovery from neuromuscular blockad...
The non-depolarizing neuromuscular block produced by Org NC45 was potentiated by the previous admini...
The neuromuscular effects of suxamethonium (single dose and continuous infusion) were determined in ...
Since the introduction of suxamethonium as a neuromuscular blocking agent [1,2], clinical reports ha...
The pattern of neuromuscular blockade during the infusion of suxamethonium in adults is well establi...
Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg s~ '...
Luis A Lee, Vassilis Athanassoglou, Jaideep J Pandit Nuffield Department of Anaesthetics, ...
We have assessed, in 200 patients, the deter-minants of the reversal time of competitive neuromuscul...
In a controlled, randomized study, we evaluated duration of neuromuscular block in 80 patients under...
Neuromuscular blocking agents are a substantial element of anaesthesia in almost every surgical fiel...
The intubating conditions and neuromuscular blocking profile following 600-mu-g.kg-1 rocuronium (Org...
At the end of an abdominal operation, muscle relaxation may be inadequate and a transient increase i...
BACKGROUND: Sugammadex is the first of a new class of selective muscle relaxant binding drugs develo...
Mivacurium chloride is a new non-depolarizing neuromuscular blocking drug, structurally related to a...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
Vecuronium has a shorter duration of action than pancuronium and recovery from neuromuscular blockad...
The non-depolarizing neuromuscular block produced by Org NC45 was potentiated by the previous admini...
The neuromuscular effects of suxamethonium (single dose and continuous infusion) were determined in ...
Since the introduction of suxamethonium as a neuromuscular blocking agent [1,2], clinical reports ha...
The pattern of neuromuscular blockade during the infusion of suxamethonium in adults is well establi...
Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg s~ '...
Luis A Lee, Vassilis Athanassoglou, Jaideep J Pandit Nuffield Department of Anaesthetics, ...
We have assessed, in 200 patients, the deter-minants of the reversal time of competitive neuromuscul...
In a controlled, randomized study, we evaluated duration of neuromuscular block in 80 patients under...
Neuromuscular blocking agents are a substantial element of anaesthesia in almost every surgical fiel...
The intubating conditions and neuromuscular blocking profile following 600-mu-g.kg-1 rocuronium (Org...
At the end of an abdominal operation, muscle relaxation may be inadequate and a transient increase i...
BACKGROUND: Sugammadex is the first of a new class of selective muscle relaxant binding drugs develo...
Mivacurium chloride is a new non-depolarizing neuromuscular blocking drug, structurally related to a...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
Vecuronium has a shorter duration of action than pancuronium and recovery from neuromuscular blockad...